Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03767335
Title MEN1611 With Trastuzumab (+/- Fulvestrant) in Metastatic Breast Cancer (B-PRECISE-01)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Menarini Group

breast adenocarcinoma


CH5132799 + Fulvestrant + Trastuzumab

CH5132799 + Trastuzumab

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | BEL

Additional content available in CKB BOOST